Sulforaphane for the treatment of ADHD
Phase 2
Recruiting
- Conditions
- ADHD.Attention-deficit hyperactivity disorder, combined typeF90.2
- Registration Number
- IRCT20090117001556N146
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age between 6-11 years
Diagnosis of ADHD based on DSM5
Exclusion Criteria
Age range outside 6-11 years
Diagnosis of a serious disease, or disease requiring surgery, or neurological diseases
Diagnosis of a psychiatric disorder and taking neuropsychiatric drugs, except for ADD
History of treatment with sulforaphane in the last three months
History of treatment with neuroleptic medication in the last six months
Weight less than 13.5 kg
Mental retardation
Seizure
A systolic blood pressure greater than 125 or a resting heart rate less than 60 or greater than 115
History of allergy to sulforaphane or methylphenidate
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of ADHD. Timepoint: Weeks: 0 , 4 , 8. Method of measurement: By ADHD Rating Scale (by parents or teacher).
- Secondary Outcome Measures
Name Time Method